NCT04210011

Brief Summary

This study is to describe the psychosocial well-being and quality of life of Hong Kong Chinese parents of children with cancer with the aim at understanding the needs and concerns of parents, including their perceptions, behaviour, attitudes, and experiences related to cancer and its treatment of their child.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
114

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 24, 2019

Completed
9 days until next milestone

Study Start

First participant enrolled

January 2, 2020

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
Last Updated

March 25, 2020

Status Verified

March 1, 2020

Enrollment Period

2.3 years

First QC Date

December 20, 2019

Last Update Submit

March 23, 2020

Conditions

Keywords

Pediatric oncologyParental resilience

Outcome Measures

Primary Outcomes (1)

  • Connor-Davidson resilience scale

    Connor-Davidson resilience scale (CD-RISC) will be used to measure the resilience level of parents having children with cancer. It contains a total of 25 items, which can be divided into 3 subcategories: (1) tenacity, (2) strength, and (3) optimism.The total possible scores of the scale range from 0 to 100, with a higher score indicating greater resilience.

    baseline

Secondary Outcomes (5)

  • The EuroQoL 5-Dimension 5-level

    baseline

  • The Center for Epidemiologic Studies Depression Scale (CES-D)

    baseline

  • The Chinese version of the State Anxiety Scale for Adults (C-SAS-A)

    baseline

  • The Multidimensional Scale of Perceived Social Support (MSPSS)

    baseline

  • Parents' perceptions, behaviour, attitudes, and experiences related to the cancer and its treatment of their child

    baseline

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hong Kong Chinese parents of children with cancer admitted to Hong Kong Children's Hospital are eligible. Study inclusion criteria for parents are as follows: (1) the primary caregiver, either father or mother, (2) ability to speak Cantonese and read Chinese-language materials, (3) having a child aged 0-16 years and diagnosed with cancer at some time in the previous month and currently undergoing active treatment. Parents with chronic illness and cognitive or learning disorders will be excluded.

You may qualify if:

  • the primary caregiver, either father or mother,
  • ability to speak Cantonese and read Chinese-language materials,
  • having a child aged 0-16 years and diagnosed with cancer at some time in the previous month and currently undergoing active treatment

You may not qualify if:

  • Parents with chronic illness and cognitive or learning disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Hong Kong

Hong Kong, Hong Kong

RECRUITING

Study Officials

  • Ho Cheung William Li, PhD

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ho Cheung William Li, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2019

First Posted

December 24, 2019

Study Start

January 2, 2020

Primary Completion

April 30, 2022

Study Completion

April 30, 2022

Last Updated

March 25, 2020

Record last verified: 2020-03

Locations